ICD-10-CM Billable Code

F18.2

Inhalant dependence

Clinical Classification Guidelines

Excludes Type 1

  • inhalant abuse (F18.1-)
  • inhalant use, unspecified (F18.9-)

Medical Intelligence & Overview

Inhalant dependence is a substance use disorder characterized by a compulsive need to inhale chemical vapors for their psychoactive effects. These substances, often found in common household products, can lead to physical and psychological dependence when used repeatedly over time. Recognizing the signs and understanding the nature of inhalant dependence is crucial for seeking appropriate help and support.

Causes & Symptoms

Clinical Causes: Accessibility to household substances such as glue, paint thinners, aerosols, and cleaning products Curiosity or peer pressure, especially among adolescents Underlying mental health conditions like depression or anxiety Lack of awareness about the risks associated with inhalant use Environmental factors, including family history of substance use disorders

Key Symptoms: Intense cravings to inhale vapors Increased tolerance, requiring higher amounts for the same effect Withdrawal symptoms such as nausea, sweating, or headaches when not using Neglect of personal and professional responsibilities Social withdrawal or isolation from family and friends Use of inhalants in secret or lying about usage Physical signs like chemical odors, paint or solvent stains on clothing or skin Impaired coordination, dizziness, or slurred speech

Diagnostic & Treatment

Diagnosis Path: Diagnosis of inhalant dependence involves a comprehensive assessment by healthcare professionals, including detailed interviews about inhalant use history, physical examinations, and observation of symptoms. Healthcare providers may use standardized criteria outlined in psychiatric manuals to confirm dependence. Detection of substances in bodily fluids like blood or urine can also support diagnosis, especially in uncertain cases.

Treatment Protocols: Medical detoxification to manage withdrawal symptoms, often under supervised care Behavioral therapies such as cognitive-behavioral therapy (CBT) to address underlying psychological issues Counseling sessions for families to support recovery and improve communication Educational programs to increase awareness about the dangers of inhalant use Participation in support groups for ongoing assistance Addressing co-occurring mental health conditions through specialized psychiatric treatment

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F18.2 a billable ICD-10 code?
Yes, F18.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F18.2?
Clinical documentation must specify the nature of Inhalant dependence and any associated comorbidities for accurate reporting.

Cite this Clinical Reference